Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Pak Med Assoc ; 53(3): 90-4, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12779020

RESUMO

OBJECTIVE: To determine the value of Helicobacter pylori (Hp) serology in diagnosis of active Hp infection in patients with documented duodenal ulcer (DU) and to directly compare the efficacy and side-effects profiles of metronidazole or tinidazole in a triple therapy regimen to eradicate active Hp infection. DESIGN OF STUDY: Prospective, single-blinded, randomised trial. METHODS: One hundred patients from General Practice with documented DU and Hp seropositivity had a C14 Urea Breath Test (UBT). Those who tested positive were randomised to receive one-week, twice daily omeprazole 20 mgs and clarithromycin 250 mgs in combination with metronidazole 400 mgs (OCM) or tinidazole 500 mgs (OCT). Eradication was confirmed by a repeat UBT. RESULTS: Eighty five sero-positive patients had a positive pre-treatment UBT. On intention to treat basis, OCT (100%) had a significantly better eradication rate than OCM (87.8%), p = 0.023. There was no difference in side effects. CONCLUSION: (1) Positive Hp serology in patients with DU does not always mean active infection and (2) for patients in the community with active Hp and DU disease OCT is significantly better than OCM for eradicating Hp.


Assuntos
Antibacterianos/uso terapêutico , Úlcera Duodenal/diagnóstico , Úlcera Duodenal/tratamento farmacológico , Infecções por Helicobacter/diagnóstico , Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori , Adulto , Idoso , Testes Respiratórios , Quimioterapia Combinada , Úlcera Duodenal/microbiologia , Feminino , Humanos , Masculino , Metronidazol/uso terapêutico , Pessoa de Meia-Idade , Estudos Prospectivos , Método Simples-Cego , Tinidazol/uso terapêutico
2.
J Pharm Biomed Anal ; 16(2): 215-21, 1997 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9408836

RESUMO

New thin layer densitometry and high performance liquid chromatography (HPLC) methods are described for quantitative determination of glafenine in dosage forms in the presence of its photo-degradation products and in serum in the presence of its metabolites. Mobile phases consisting of toluene-isopropyl alcohol-dimethylformamide-water (18:3:1:0.5) and methanol-water-phosphoric acid (80:120:0.5) are found to be efficient for reasonable separation and adequate resolution of glafenine from associated substances by thin layer chromatography (TLC) and HPLC techniques, respectively. The methods are used for the study of glafenine purity, stability, bioavailability, bioequivalence and tablet dissolution rate. The results obtained by TLC and HPLC techniques are in good agreement and offer the advantages of reproducibility and accuracy.


Assuntos
Analgésicos não Narcóticos/sangue , Cromatografia Líquida de Alta Pressão/métodos , Cromatografia em Camada Fina/métodos , Glafenina/sangue , Analgésicos não Narcóticos/análise , Analgésicos não Narcóticos/química , Animais , Disponibilidade Biológica , Densitometria , Estabilidade de Medicamentos , Glafenina/análise , Glafenina/química , Masculino , Ratos , Ratos Sprague-Dawley , Comprimidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...